CoGenesis® Neuro
Refining neuro-degeneration diagnoses
Neurodegenerative conditions affect over 400 million people worldwide. In Hong Kong, one in 67 people is diagnosed with a neurodegenerative disease. Our testing can shorten the diagnostic time from up to twenty years, to just six weeks.
Order now Download Brochure

About CoGenesis® Neuro

Who should consider testing

  • People with a family history of neuro-related conditions, developmental delays, seizures, muscle weakness or gait abnormalities.
  • Patients receiving conventional care but are experiencing an unexplained worsening of their condition.
  • People with neurodegenerative symptoms and an unclear diagnosis.

An early and accurate diagnosis

Our testing can help diagnose neurodegenerative
diseases including Parkinson’s disease, Charcot-Marie-Tooth Neuropathy, Epilepsy, Spastic Paraplegia, Spinocerebellar Ataxia and Spinal Muscular Atrophy, among many others.
Full screening of

31,272

neuro-related areas of the genome
Screening for

313

neuro disease genes in one test
Accurate diagnosis in just

6 weeks

Plan for your life and your family

Neurodegenerative diseases have a slow rate of progression. A prompt precise diagnosis means tailored effective treatment could be started earlier. As of 2020, over 200 treatments are available for rare diseases.

Bridging the gap

By integrating genetic and clinical information, our screening produces more accurate data, connects professionals and speeds up the diagnosis process.

The process

1

A blood sample is taken.

2

The sample then undergoes targeted next-generation sequencing.

3

Any mutations are identified and diagnosis is confirmed.

4

Results are shared securely on the Codex website within six weeks of receipt of sample.

Case Study

From unknown diagnosis to effective treatment

A middle-aged patient presented with ataxia and a spastic gait. The diagnosis was unknown.

They had a DNA sample taken for the CoGenesis® Neuro test, which integrated their reported symptoms and detected genetic variants.

Using CoGenesis® Bioinformatics, the patient was successfully diagnosed as having Spastic Paraplegia 11, for which treatment (GSK3 inhibitor) is available.

All Codex products are available at Hong Kong Health Check (HKHC) Centres. You can enjoy a discount on your HKHC checkup following a complete Codex service.

Learn More

Any questions?

EXPLORE FAQs

CoGenesis® Cancer

Decoding cancer

Learn more

CoGenesis® Drug Response

Optimising medication

Learn more